Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index

International Journal of Obesity

Volumn 22, Issue 6, 1998, Pages 559-566

  Allison, D B ^a,b   Heo, M ^a   Faith, M S ^a   Pietrobelli, A ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

BMI; Meta analysis; Obesity; Pooling; Trp64Arg; 3 adrenergic receptor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ARTICLE; BODY MASS; DIABETES MELLITUS; ETHNOLOGY; GENE LOCUS; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; META ANALYSIS; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0031781779     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800625     Document Type: Article

References (42)

1. Maes MHM, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Gen 1997; 27: 325-351.
2. Bouchard C, Pérusse L. Current status of the human obesity gene map. Obes Res 1996; 4: 81-90.
3. 3-adrenergic-receptor-gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351.
4. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
5. 3-adrenergic receptor gene has no effect on obesity phenotypes in the Québec family study and Swedish obese subjects cohorts. J Clin Invest 1996; 98: 2086-2093.
6. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 1996; 19: 271-272.
7. 3 adrenergic-receptor-gene. N Engl J Med 1995; 333: 343-347.
8. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-354.
9. 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433-1434.
10. 3-adrenergic receptor gene. Diabetes 1996; 45: 1115-1120.
11. 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes 1996; 20: 1051-1054.
12. 3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-352.
13. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 1996; 19: 1034-1035.
14. 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857-860.
15. 3-adrenergic receptor gene Trp64Arg mutations is overrepresented in obese women. Diabetes 1996; 45: 1358-1363.
16. 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4155-4158.
17. 3-adrenergic receptor gene with NIDDM, current and maximal body mass index. Diabetologia 1996; 39: 1410.
18. 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996; 81: 4422-4427.
19. 3-adrenergic receptor gene in morbid obesity. Int J Obes 1996; 20: 1055-1061.
20. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 1997; 46: 77-80.
21. 3-adrenergic polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997; 40: 200-204.
22. 3-adrenergic receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa. Int J Obes 1997; 21: 224-230.
23. 3-adrenergic receptor in essential hypertension; insulin resistance and the adrenergic system. Am J Hypertens 1997; 10: 101-105.
24. 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 1997; 82: 1284-1287.
25. 3-adrenergic receptor Trp64Arg polymorphism and obesity in Alaskan Eskimos. Int J Obes 1997; 21: 1176-1179.
26. 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. Diabetologia 1996; 39: 1505-1511.
27. 3-adrenergic receptor gene polymorphisms and determination of adiposity and fat distribution in normal female twins. Diabetologia 1997; 40: 122-123.
28. 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997; 40: 469-472.
29. 3-adrenergic receptor gene in Japanese subjects. Metabolism 1997; 46: 199-202.
30. Cox DR, Hinkley DV. Theoretical Statistics. Chapman & Hall: London, 1974, pp 147-149.
31. Seber GAF. Linear regression analysis. John Wiley & Sons: New York, London, Sydney, Toronto, 1977.
32. Raudenbush SW. Random effects models. In: Copper H, Hedges LV (eds). The handbook of research synthesis. Russell Sage Foundation: New York, 1994.
33. 3-adrenergic receptor gene variant and Japanese NIDDM: a pitfall in meta-analysis. Lancet 1996; 348: 896-897.
34. 3-adrenergic receptor does not relate to body weight in healthy, premenopausal women. Int J Obes 1997; 21: 826-829.
35. 3-adrenergic receptor gene polymorphism is not a major determinant of obesity and diabetes in Japanese general population. Diab Res Clin Pract 1997; 37: 1-7.
36. 3-adrenergic receptor codon 64 variant is not associated with age-at-diagnosis of NIDDM nor with obesity in the FUSION (Finnish US Investigation of NIDDM) study. (abstr). Diabetes 1996; 45(suppl. 2): 229A.
37. Allison DB, Faith MS, Gorman BS. Publication bias in obesity treatment trials. Int J Obes 1996; 20: 931-937.
38. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
39. Murphy EA. Biostatistics in medicine. The Johns Hopkins University Press: Baltimore and London, 1982.
40. Rissanen J, Kuopusjarvi J, Pihlajamki J, Sipilainen R, Heikkenen S, Vanhala M, Kekalainen P, Kuusisto J, Laasko M. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene: Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997; 20: 1319-1323.
41. 3 adrenergic receptor mutation. Endocrinology 1996; 137: 2638-2641.
42. 3-adrenoreceptor activity. Eur J Biochem 1997; 247: 1174-1179.